Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes

Summary

evaluate the safety and tolerability of ITCA 650 in subjects with type 2 diabetes mellitus.

Timeline

Start

2009-02

Primary completion

2009-05

Completion

2009-05

Publications

• Henry RR, Logan D, Alessi T, Baron MA. A randomized, open-label, multicenter, 4-week study to evaluate the tolerability and pharmacokinetics of ITCA 650 in patients with type 2 diabetes. Clin Ther. 2013 May;35(5):634-645.e1. doi: 10.1016/j.clinthera.2013.03.011. Epub 2013 Apr 8.

Drugs

Indications